Skip to main content
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp — Investor Relations & Filings

Ticker · UTHR ISIN · US91307C1027 LEI · 5299005C4HZL4UWROC14 US Manufacturing
Filings indexed 2,876 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country US United States of America
Listing US UTHR

About UNITED THERAPEUTICS Corp

https://www.unither.com/

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapies for chronic and life-threatening conditions. The company's primary therapeutic areas include pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also develops treatments for pediatric neuroblastoma. In addition to its pharmaceutical pipeline, United Therapeutics is actively engaged in research and development of technologies to manufacture transplantable organs and tissues, aiming to address the shortage of donor organs.

Recent filings

Filing Released Lang Actions
8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Regulatory Filings
2026-05-06 English
10-Q - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Interim / Quarterly Report
2026-05-06 English
ARS - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Annual Report
2026-04-29 English
DEF 14A - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Proxy Solicitation & Information Statement
2026-04-29 English
8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Regulatory Filings
2026-03-30 English
4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
Director's Dealing
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.